Revlimid Package insert


  • Pill
  • Mantle cell lymphoma
  • Relapse or progression after 2 prior therapies
  • 1 of which included bortezomib Multiple myeloma
  • In combination with dexamethasone
  • In patients who have received at least 1 prior therapy Myelodysplastic syndrome
  • Transfusion-dependent
Back to: Full Site Navigation

FDA package inserts for Revlimid (Lenalidomide)

This is the FDA package insert, supplied by pharmaceutical companies

Downloading FDA Package Insert for Revlimid capsule